AstraZeneca to make ‘modest profit’ from coronavirus vaccine, but not from developing countries

Nov 12, 2021 | INVESTING

British-Swedish pharmaceutical company AstraZeneca will start to make a modest profit from its coronavirus vaccine as it moves away from the non-profit model it has operated during the pandemic.In a third-quarter update, the company said on Friday it is “now expecting to progressively transition the vaccine to modest profitability as new orders are received.”However, it said it will not be making any coronavirus vaccine profits from developing countries.Safety and effectiveness of China’s Covid…

Read More

Pin It on Pinterest